Today these two fellows rocked their VENIA DOCENDI

🎓David CHROMY : STIs & #HepatitisC
🎓Mathias JACHS : NITs in #PortalHypertension

my personal highlights:

@mathiasjachs.bsky.social in @lancetgastrohep.bsky.social
Spleen Stiffness
🔗 t.ly/DysXB

Chromy in #UEGJ
DAAs in acute #HCV
🔗 t.ly/nIZ2a

ein Diagramm des Gewichtsverlusts

What drives meaningful weight loss in patients with MASLD?

In this study of 897 patients with metabolic dysfunction-associated steatotic liver disease (MASLD), only 18.3% achieved a ≥7% weight loss over ~21 months despite lifestyle counselling.

👉 Read more in #UEGJ: https://bit.ly/44tY4r4

In this real-world, multicenter study rifaximin-α significantly reduced:

✅ Episodes of hepatic encephalopathy (−60%)
✅ Hospital admissions and emergency room visits
✅ Outpatient clinic visits
✅ Overall healthcare utilization

#UEGJ

a poster with a cartoon image of poop and a dropper

💩 #Calprotectine did not disappoint, not even in the most difficult #IBD phenotype-perianal.
Scraping calpro correlates with Crohn's fistula severity ➡️ clinically relevant for 🪡 tailored therapy.

🔗 Access in UEG Journal: https://bit.ly/3WT5yj5

#UEGJ #myUEGcommunity